ADDvisor 

For People with ADHD & Those Who Love Them

Subscribe Me to the ADDvisor Newsletter Bill Benninger Alan Graham

Home Page

ADDvisor Store - Tapes

Cogmed Working Memory Training

Newsletter

ADDvisor Teleconferences

OWNER'S MANUAL Series

Outline: Everything You Want To Know About ADHD

Coaching for Adults with ADHD

Why Parent Education?

What People Say 

ADHD Books and Resources

Links

About Us

Contact Us

 

Return to ADDvisor Volume 2 2000 Index

Number 18 September 15, 2000

In this issue:

1. Clinical Subtypes of ADHD and Medication

2. Resources - The Anxiety and Phobia Workbook

CLINICAL SUBTYPES OF ADHD AND MEDICATION

 

Wednesday night I attended a lecture by Robert D. Hunt, MD, a psychiatrist from Nashville, TN. The lecture was sponsored by Shire, the company that makes Adderall. As part of his talk, Dr. Hunt described the clinical subtypes of ADHD. He called them:

Cognitive Dysfunction: Inattention

Overaroused: Hyperactivity

Behavioral Inhibition: Impulsive

 

Cognitive Dysfunction: Inattention Subtype

                    Symptoms: Distractibility, Disorganization

                    Co-existing: Depression, Anxiety, LD

                    Course: Later Onset; Persistent Course

                    Gender: Equal male and female

                    Medication: Stimulants

This appears to be ADD without hyperactivity. Because these individuals are not troublemakers, they are identified later but their problems persist. Dr. Hunt reported that these individuals respond to stimulants (Adderall, Ritalin, Dexedrine).

Overaroused: Hyperactivity Subtype

                    Symptoms: High Activity; Aggression

                    Co-existing: Acting out, Aggression, ADHD

                    Course: Early Onset; Diminishing Course

                    Gender: More males than females

                    Medications: Clonidine; Tenex

The hyperactive kids are picked up fairly quickly because they are such a handful. Their course is "diminishing" because as they grow into adolescence and adulthood, their hyperactivity often transforms into a subjective restlessness. Clonidine or Tenex are used to help "slow them down." Dr. Hunt calls this type, the "Tornado."

Behavioral Inhibition: Impulsive Subtype

                 Symptoms: Excessive talking, Touching, Reacting

                Co-existing: Oppositionality, Aggression

                Course: Later Onset; Decreasing Course

                Gender: Equal males and females

                Medications: SSRIs (Prozac, Paxil, Zoloft, Luvox, Effexor, Serzone, Celexa) and         Stimulants (Adderall, Ritalin, Dexedrine)

Individuals of this subtype are described as immature, emotive, talkative, touching, moody. They often behave inappropriately. Social skills are often a problem. Medication combinations are often used with this subtype.

Dr. Hunt also talked about "sculpting" the medication dose for the individual. Medication choice and dosages are determined by factors of age, mood and aggressivity.

Factor of Age

When using stimulants, Preschool and primary age children may be given Ritalin or a combination of Tenex and Adderall (as young ADHD patients are more likely the hyperactive type). Adolescents are given Adderall, Ritalin or Cylert. Adults are given Adderall or Dexedrine Spansules.

Factor of Mood

If the ADD individual is depressed, the irritable patient will be given Paxil or Effexor. The anergic (reduced sensitivity) patient is given Wellbutrin or Celexa. The bipolar patient is prescribed Carbatrol, Depakote or Lithium.

Factor of Aggression

If the aggressive patient is hyperactive, Ritalin or Tenex plus Adderall is prescribed. The very emotional aggressive individual is either treated with Carbatrol or Depakote for their mood instability or Effexor or Paxil for depressive symptoms. The impulsive-aggressive patient is treated with Inderal or Tenormin; or with Adderall.

Dr. Hunt stated that these choices are not necessarily the only ways that these conditions should be treated. Many other factors may play into the medication decision. If you or someone in your family is taking medication, you should always be following up with the prescribing physician.

As always, the only way medication can be effective is if it is taken in accordance with the physician’s directions.

Dr. Robert Hunt is the Medical Director and CEO of Centers for Attention. His web site is www.centerforattention.com. He also is at Vanderbilt University.

RESOURCES

 

Anxiety is often a co-existing problem that accompanies ADHD, especially in older adolescents and adults. To help manage anxiety, I recommend The Anxiety and Phobia Workbook by Edmund Bourne.

 

CONTACT INFORMATION

_______________________

Alan R. Graham, Ph.D. 

Bill Benninger, Ph.D.

ADDvisor.com

Voice: 1-866-ADDvisor

Fax: 847-824-2386

Email: Alan@ADDvisor.com

Bill@ADDvisor.com

Web: www.ADDvisor.com

 

 

c) Copyright 2000 Alan R. Graham and Bill Benninger. All rights reserved

The above material may be retransmitted or distributed to whomever you wish as long as not a single word is changed, added or deleted, including the contact information. However, you may not copy it to a web site.

Republication of "The ADDvisor" in paper media is encouraged and permitted by organizations and associations which serve parents of ADHD children at the national, state and/or local level as long as the issue is reprinted in its entirety without charge and includes the contact information. With advance permission, we are happy to edit an issue to fit your space requirements.

Republication is also encouraged under other circumstances, however, the advance permission of Alan R. Graham and/or Bill Benninger must be obtained in the event that changes in the text are desired or republication is to be made by individuals or by organizations other than those mentioned above.

 

 

 

                                                Questions or comments? Send e mail to Alan@ADDvisor.com  
                                                Copyright © 2007 ADDvisor.com, Ltd.
                                                Last modified: March 22, 2007